![Valerie Morisset](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Valerie Morisset is the founder.
Dr. Morisset was the founder of Climb Bio, Inc. (2018) as Chief Scientific Officer, EVP & Head-R&D.
Dr. Morisset was also the founder of Convergence Pharmaceuticals Ltd. Dr. Morisset is currently the Director at Eliem Therapeutics (UK) Ltd. since 2019.
Former jobs include Principal at GlaxoSmithKline LLC and Venture Partner at Bridge Valley Ventures LLP (2018-2019).
Education includes a graduate degree from Université de Bordeaux.
| Sociétés | Poste | Début |
|---|---|---|
Eliem Therapeutics (UK) Ltd.
 Eliem Therapeutics (UK) Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Directeur/Membre du Conseil | 18/12/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
| CLIMB BIO, INC. | Fondateur | 23/08/2024 |
Bridge Valley Ventures LLP
 Bridge Valley Ventures LLP Investment ManagersFinance Bridge Valley Ventures invests in companies located in the UK, Europe and North America. The firm focuses on oncology, neuroscience, immunology and rare diseases therapeutics, pharma/biotech sector. They provide financing for buyout transaction. | Corporate Officer/Principal | 01/03/2019 |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops neuropathic pain products | Fondateur | 01/01/2018 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 6 |
|---|---|
Université de Bordeaux
 Université de Bordeaux Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops neuropathic pain products | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Bridge Valley Ventures LLP
Bridge Valley Ventures LLP Investment ManagersFinance Bridge Valley Ventures invests in companies located in the UK, Europe and North America. The firm focuses on oncology, neuroscience, immunology and rare diseases therapeutics, pharma/biotech sector. They provide financing for buyout transaction. | Finance |
Eliem Therapeutics (UK) Ltd.
Eliem Therapeutics (UK) Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
